Case could provide first road map for how a U.S. president can remove a member of central bank’s governing body ...

The roof is one of the most expensive components of a commercial or industrial property. It protects everything inside yet, ...

Avoid these mistakes to build automation that survives UI changes, validates outcomes properly, and provides useful feedback.

Group calls for review of retailer’s partnership with Flock Safety, whose data has been used in ​immigration enforcement ...

Visitors to your website might want directions to your store via Google Maps, a roundup of your social media feeds, and a ...

The European Commission has approved BridgeBio's acoramidis for life-threatening heart disorder transthyretin amyloidosis cardiomyopathy (ATTR-CM), setting up a market clash with Pfizer. The oral drug ...

Bayer has shored up its near-term pipeline by acquiring European rights to acoramidis from BridgeBio and Eidos Therapeutics, putting some big pharma muscle behind the therapy for transthyretin amyloid ...

ARKF offers thematic returns through growth stock exposure, benefiting from pro-risk environments and tech rallies. See why ...

If you’ve been watching your analytics lately, you might have noticed a confusing trend: organic search numbers are dipping, ...

The successful commercialization of Attruby could establish BridgeBio as a key player in the ATTR-CM market, significantly improving its path to profitability.